Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Authors

Showing 3 results for author "Hunan Julhakyan".

Back to authors

Thumbnail for Addition of Fixed Low-Dose Nivolumab to R-DA-EPOCH Is Associated With Improved Event-Free Survival in Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PMBCL)

ABCL - 1390

Addition of Fixed Low-Dose Nivolumab to R-DA-EPOCH Is Associated With Improved Event-Free Survival in Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PMBCL)

Hunan Julhakyan

Poster Presenter: Hunan Julhakyan

Thumbnail for Preliminary Outcomes of Treatment in Young Patients With B-Cell Chronic Lymphocytic Leukemia and Poor Prognostic Indicators Utilizing the FCR Regimen Combined With Ibrutinib and Venetoclax in a Fixed-Duration Protocol

CLL - 1376

Preliminary Outcomes of Treatment in Young Patients With B-Cell Chronic Lymphocytic Leukemia and Poor Prognostic Indicators Utilizing the FCR Regimen Combined With Ibrutinib and Venetoclax in a Fixed-Duration Protocol

Hunan Julhakyan

Poster Presenter: Hunan Julhakyan

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for PET-GUIDED NIVOLUMAB-BASED FIRST-LINE STRATEGY IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM CLINICAL RESULTS

HL - 1412

PET-GUIDED NIVOLUMAB-BASED FIRST-LINE STRATEGY IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM CLINICAL RESULTS

Hunan Julhakyan

Poster Presenter: Hunan Julhakyan

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors